VantAI

Operations

• Internal R&D Program Management – Oversee timelines, deliverables, and cross-functional coordination for high-priority internal R&D programs
• NeoLink Platform Strategy – Support platform-related initiatives, from experiment planning to data integration, ensuring the science and operations run seamlessly
• CRO Management - Oversee VantAI’s entire CRO portfolio ensuring alignment with program priorities and timelines
• Operational Infrastructure – Build, optimize, implement processes, tools, and workflows that enhance communication, automate repetitive tasks, and keep the company operating at peak efficiency
• Strategic & Competitive Insights – Conduct benchmarking, strategy and competitive landscaping to inform decision-making, uncover opportunities, and identify potential risks
• Manage relationships with Key Opinion Leaders (KOLs) and members of our Scientific Advisory Board
• VantAI is seeking a Senior Associate, Strategy & Operations to build the strategic and operational foundation for our next stage of growth. In this high-impact role, you will work directly with the C-Suite and broader leadership team to oversee critical R&D workflows, connect the dots across the organization, and ensure timely execution of our highest priority initiatives. You’ll own the management of our CRO portfolio, drive strategy and operations for internal programs and our NeoLink platform, support key external relationships, and set roadmaps and benchmarks that enable VantAI to remain at the top of our competitive landscape.
• About VantAI: VantAI is building artificial intelligence to revolutionize drug discovery and development. We produce technology to help scientists deliver novel compounds for life saving therapies. We were launched by Roivant Sciences, a global biopharma focused on rapidly developing innovative medicines and drug development technologies. Working together with some of the world’s leading biopharmaceutical companies, we design, test and optimize novel therapies to treat some of the world’s most difficult diseases.